KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Boston Scientific (BSX) FCF Margin (2016 - 2026)

Boston Scientific's FCF Margin history spans 18 years, with the latest figure at 3.29% for Q1 2026.

  • On a quarterly basis, FCF Margin fell 431.0% to 3.29% in Q1 2026 year-over-year; TTM through Mar 2026 was 16.86%, a 31.0% decrease, with the full-year FY2025 number at 18.22%, up 243.0% from a year prior.
  • FCF Margin hit 3.29% in Q1 2026 for Boston Scientific, down from 19.16% in the prior quarter.
  • Over the last five years, FCF Margin for BSX hit a ceiling of 25.85% in Q4 2024 and a floor of 5.92% in Q1 2022.
  • Historically, FCF Margin has averaged 12.62% across 5 years, with a median of 14.4% in 2023.
  • The widest YoY moves for FCF Margin: up 1157bps in 2022, down -1351bps in 2022.
  • Tracing BSX's FCF Margin over 5 years: stood at 18.35% in 2022, then increased by 1bps to 18.52% in 2023, then surged by 40bps to 25.85% in 2024, then decreased by -26bps to 19.16% in 2025, then crashed by -83bps to 3.29% in 2026.
  • Business Quant data shows FCF Margin for BSX at 3.29% in Q1 2026, 19.16% in Q4 2025, and 22.94% in Q3 2025.